Dr Pavan Bhargava gives insights on earlier diagnosis, ocrelizumab safety in pregnancy, and promising anti-aging effects of diet in RRMS.

Dr Nicholas Silvestri reports that the 2025 AAN meeting highlighted significant advances in myasthenia gravis, including improved diagnostics and emerging therapies.

Agility Public Warehousing Company of Kuwait is buying the American company G2 Secure Staff, one of the world’s largest aviation service providers, for $305 million. G2 provides aviation support ...

Long-term data from the VISIONARY-MS Phase 2 trial links improved brain imaging and visual evoked potentials to remyelination and neuronal repair in MS patients treated with CNM-Au8.

Airport ground services firm Menzies Aviation, a subsidiary of Agility Global, has signed a deal to acquire US-based G2 for $305 million, in a bid to strengthen its presence in the American market and ...

非处方（OTC）止痛药已被证明可以减轻创伤性脑损伤（TBI）后的神经炎症。然而，评估非处方止痛药对脑震荡后临床疗效的循证研究却很少。根据近日在美国神经病学学会第77届年会上发布的一项研究数据，创伤性脑损伤后使用非处方止痛药（包括对乙酰氨基酚和非甾体抗炎药[NSAID]）与脑震荡症状的改善和康复有显著相关性。研究简 ...

Mazaya Developments prepares to launch a new real estate project in east Cairo during the second half of 2025, as part of the ...

近日（2025年4月5日-9日），全球瞩目的神经领域年度盛会——第77届美国神经病学会（AAN）年会在美国圣地亚哥隆重召开。全球超10000名神经科学领域的知名学者齐聚一堂，共飨盛宴，众多神经领域前沿进展惊艳亮相，其中重症肌无力（MG）的研究进展更是 ...

PrimeC has demonstrated promising results in the 18-month Phase 2b trial, with data highlighting its potential as a disease-modifying therapy for ALS. The trial revealed a marked reduction in ALS ...

Phase 3 IFT Study results presented at AAN 2024 show that IV fosphenytoin provides fast, significant pain relief for acute ...

One in three women will become pregnant after an MS diagnosis, therefore consideration of the maternal-infant dyad is needed.

Breaking Science Session at the 2025 American Academy of Neurology (AAN) meeting, Remegen announced exciting results from a ...